Treat and Extend versus Pro Re Nata regimens of ranibizumab in neovascular age‐related macular degeneration: a comparative 12 Month study

ConclusionRanibizumab administered using a TE regimen in treatment‐naïve patients with nAMD provided better visual outcomes with fewer clinic visits, compared with a PRN regimen.

Source: Acta Ophthalmologica - March 23, 2016 Category: Opthalmology Authors: Katja Hatz, Christian Prünte Tags: Case Series Source Type: research